The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...

Indiana's workforce is feeling pressure to return to the office, but a good portion of employees still like hybrid work. Is ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

A woman's hands star in a Lilly spot, shown playing key role in activities like gardening -- and discovering a lump in her ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Eli Lilly continues to be a signif... "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ...

Warren Buffett Sends Wall Street a Grim $127 Billion Warning: History Says the Stock Market Will Do This in 2025. Warren Buffett Sold Over $134 Billion Worth of Stock in 2024, But His Most Recent ...

Eli Lilly has announced plans to acquire Scorpion Therapeutics ... as per a consensus forecast by GlobalData, the parent company of Pharmaceutical Technology. PI3K inhibitors are directed toward the ...